{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:53:36Z","timestamp":1775307216103,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA037287"],"award-info":[{"award-number":["R01DA037287"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DA026946"],"award-info":[{"award-number":["R01DA026946"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA024022"],"award-info":[{"award-number":["DA024022"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA044855"],"award-info":[{"award-number":["DA044855"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32DA007027"],"award-info":[{"award-number":["T32DA007027"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejphar.2018.12.021","type":"journal-article","created":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T12:40:08Z","timestamp":1544618408000},"page":"175-182","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys"],"prefix":"10.1016","volume":"844","author":[{"given":"Jeremy C.","family":"Cornelissen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Floyd F.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebekah D.","family":"Tenney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Obeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenner C.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8934-7016","authenticated-orcid":false,"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew L.","family":"Banks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.12.021_bib1","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00213-014-3719-7","article-title":"Effects of the novel, selective and low-efficacy mu opioid receptor ligand NAQ on intracranial self-stimulation in rats","volume":"232","author":"Altarifi","year":"2015","journal-title":"Psychopharmacology"},{"issue":"5","key":"10.1016\/j.ejphar.2018.12.021_bib2","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1213\/ANE.0000000000002500","article-title":"Opioids for the treatment of chronic pain: mistakes made, lessons learned, and future directions.","volume":"125","author":"Ballantyne","year":"2017","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ejphar.2018.12.021_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pbb.2010.07.019","article-title":"Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics","volume":"97","author":"Banks","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.12.021_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1124\/jpet.110.169276","article-title":"Antinociceptive interactions between Mu-opioid receptor agonists and the serotonin uptake inhibitor clomipramine in rhesus monkeys: role of Mu agonist efficacy","volume":"335","author":"Banks","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1124\/jpet.117.246439","article-title":"Application of receptor theory to the design and use of fixed-proportion Mu-opioid agonist and antagonist mixtures in rhesus monkeys","volume":"365","author":"Cornelissen","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/FBP.0000000000000336","article-title":"Additive and subadditive antiallodynic interactions between \u03bc-opioid agonists and N-methyl D-aspartate antagonists in male rhesus monkeys","volume":"29","author":"Cornelissen","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1124\/jpet.112.194308","article-title":"Roles of mu-opioid receptors and nociceptin\/orphanin FQ peptide receptors in buprenorphine-induced physiological responses in primates","volume":"343","author":"Cremeans","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2015.08.012","article-title":"Nociceptin\/orphanin FQ receptor and pain: feasibility of the fourth opioid family member","volume":"766","author":"Di Cesare Mannelli","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/bja\/aep129","article-title":"Simultaneous targeting of multiple opioid receptors: a strategy to improve side-effect profile","volume":"103","author":"Dietis","year":"2009","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.ejphar.2018.12.021_bib10","first-page":"970","article-title":"Using the CDC guideline and tools for opioid prescribing in patients with chronic pain","volume":"93","author":"Dowell","year":"2016","journal-title":"Am. Fam. Phys."},{"key":"10.1016\/j.ejphar.2018.12.021_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/0091-3057(79)90205-3","article-title":"Interactions of acetylmethadol or methadone with other drugs in rhesus monkeys","volume":"10","author":"Downs","year":"1979","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2018.12.021_bib12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1254\/jjp.85.282","article-title":"TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys","volume":"85","author":"Endoh","year":"2001","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s002130050490","article-title":"Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys","volume":"135","author":"Gatch","year":"1998","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2018.12.021_bib14","article-title":"Targeting multiple opioid receptors \u2013 improved analgesics with reduced side effects?","author":"Gunther","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pain.2009.10.026","article-title":"Long-lasting antinociceptive spinal effects in primates of the novel nociceptin\/orphanin FQ receptor agonist UFP-112","volume":"148","author":"Hu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2018.12.021_bib16","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1073\/pnas.090514397","article-title":"A synthetic agonist at the orphanin FQ\/nociceptin receptor ORL1: anxiolytic profile in the rat","volume":"97","author":"Jenck","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.12.021_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.bjp.0700942","article-title":"Bidirectional modulatory effect of orphanin FQ on morphine\u2010induced analgesia: antagonism in brain and potentiation in spinal cord of the rat","volume":"120","author":"Jin\u2010Hua","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib18","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.jpain.2008.11.006","article-title":"Antinociceptive effects of nociceptin\/orphanin FQ administered intrathecally in monkeys","volume":"10","author":"Ko","year":"2009","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2018.12.021_bib19","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1038\/npp.2009.33","article-title":"Behavioral effects of a synthetic agonist selective for nociceptin\/orphanin FQ peptide receptors in monkeys","volume":"34","author":"Ko","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejphar.2018.12.021_bib20","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-017-4758-7","article-title":"Dissociable effects of the kappa opioid receptor agonist nalfurafine on pain\/itch-stimulated and pain\/itch-depressed behaviors in male rats","volume":"235","author":"Lazenka","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2018.12.021_bib21","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1021\/jm801272c","article-title":"Design, synthesis, and biological evaluation of 6alpha- and 6beta-N-heterocyclic substituted naltrexamine derivatives as mu opioid receptor selective antagonists","volume":"52","author":"Li","year":"2009","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2018.12.021_bib22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1124\/jpet.114.216648","article-title":"Impact of efficacy at the mu-opioid receptor on antinociceptive effects of combinations of mu-opioid receptor agonists and cannabinoid receptor agonists","volume":"351","author":"Maguire","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib23","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejphar.2008.11.004","article-title":"Role of delta opioid efficacy as a determinant of mu\/delta opioid interactions in rhesus monkeys","volume":"602","author":"Negus","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00008877-200211000-00005","article-title":"Delta opioid antagonist effects of buprenorphine in rhesus monkeys","volume":"13","author":"Negus","year":"2002","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib25","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00213-010-2012-7","article-title":"The effects of nociceptin\/orphanin FQ receptor agonist Ro 64-6198 and diazepam on antinociception and remifentanil self-administration in rhesus monkeys","volume":"213","author":"Podlesnik","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejphar.2018.12.021_bib26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejphar.2007.10.031","article-title":"Effects of nociceptin\/orphanin FQ receptor (NOP) agonist, Ro64-6198, on reactivity to acute pain in mice: comparison to morphine","volume":"579","author":"Reiss","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1124\/jpet.115.231134","article-title":"Characterization of the discriminative stimulus effects of a NOP receptor agonist Ro 64-6198 in rhesus monkeys","volume":"357","author":"Saccone","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/FBP.0000000000000437","article-title":"Sex differences in the effectiveness of buprenorphine to decrease rates of responding in rhesus monkeys","author":"Schwienteck","year":"2018","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.021_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0022-3565(24)37462-2","article-title":"Signal transduction correlates of mu opioid agonist intrinsic efficacy: receptor-stimulated [35S]GTP gamma S binding in mMOR-CHO cells and rat thalamus","volume":"285","author":"Selley","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1124\/jpet.116.232421","article-title":"Antinociceptive interactions between the imidazoline I2 receptor agonist 2-BFI and opioids in rats: role of efficacy at the mu-opioid receptor","volume":"357","author":"Siemian","year":"2016","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib31","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/jpet.103.056515","article-title":"Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception","volume":"307","author":"Stevenson","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib32","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1124\/jpet.103.058602","article-title":"Activation of G-proteins by morphine and codeine congeners: insights to the relevance of O- and N-demethylated metabolites at mu- and delta-opioid receptors","volume":"308","author":"Thompson","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.ejphar.2018.12.021_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/Orphanin FQ receptor structure, signalling, ligands, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2018.12.021_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3565(25)39351-1","article-title":"Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency","volume":"267","author":"Walker","year":"1993","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0022-3565(25)09651-X","article-title":"Buprenorphine antagonism of mu opioids in the rhesus monkey tail-withdrawal procedure","volume":"273","author":"Walker","year":"1995","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2018.12.021_bib36","doi-asserted-by":"crossref","first-page":"6405","DOI":"10.1016\/j.bmc.2013.08.042","volume":"21","author":"Zaidi","year":"2013","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:57:57Z","timestamp":1775303877000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918307313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":36,"alternative-id":["S0014299918307313"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.021","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}